SYSTEMIC SIDE-EFFECTS ASSOCIATED WITH THE OPHTHALMIC ADMINISTRATION OF TIMOLOL

被引：50

作者：

MUNROE, WP ^{[1
]}

RINDONE, JP ^{[1
]}

KERSHNER, RM ^{[1
]}

机构：

[1] ARIZONA COLL PHARM,VET ADM MED CTR,TUCSON,AZ

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1985年 / 19卷 / 02期

关键词：

D O I：

10.1177/106002808501900201

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：85 / 89

页数：5

共 52 条

[1] ADLER GA, 1982, ARCH INTERN MED, V142, P2293
[2] DYNAMICS AND KINETICS OF OPHTHALMIC TIMOLOL
AFFRIME, MB
LOWENTHAL, DT
TOBERT, JA
SHIRK, J
COOK, T
ONESTI, G
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) : 471 - 477
[3] AHMAD S, 1979, LANCET, V2, P1028
[4] TIMOLOL-INDUCED CONGESTIVE HEART-FAILURE
ALTUS, P
[J]. SOUTHERN MEDICAL JOURNAL, 1981, 74 (01) : 88 - 88
[5] ABSORPTION OF OCULAR TIMOLOL
ALVAN, G
CALISSENDORFF, B
SEIDEMAN, P
WIDMARK, K
WIDMARK, G
[J]. CLINICAL PHARMACOKINETICS, 1980, 5 (01) : 95 - 100
[6] BLIKA S, 1982, ACTA OPHTHALMOL, V60, P967
[7] BLONDEAU P, 1983, CAN J OPHTHALMOL, V18, P18
[8] BOGER WP, 1978, OPHTHALMOLOGY, V85, P259
[9] BRITMAN NA, 1979, NEW ENGL J MED, V300, P566
[10] BURGGRAF GW, 1980, CAN J OPHTHALMOL, V15, P159